← Back to the feed
Equity4576D.Western Therapeutics Institute, Inc. · TSE Growth

D.Western Therapeutics Institute Reports June Exercise Status of 13th Tranche Warrant

TOKYO, Jul 01 (Pulse News Wire) – D.Western Therapeutics Institute, Inc. (4576.T) reported the exercise status of its 13th tranche warrant (with adjustment clause) for the month of June 2026. The warr

– D.Western Therapeutics Institute, Inc. (4576.T) reported the exercise status of its 13th tranche warrant (with adjustment clause) for the month of June 2026.

The warrants were issued on July 31, 2025. In June, no shares were delivered due to exercised warrants, maintaining the total number of outstanding warrants at 9,098. At the end of June, the number of unexercised warrants stood at 9,098. The exercise ratio remained unchanged at 0.00% of the total issuance.

Detailed exercise activities during June included no deliveries on multiple days, with the highest daily exercise count being one warrant on June 12. As of the end of May, the total issued shares stood at 57,483,412, including self-held shares of 11,387. Regarding exercise limitations based on the Tokyo Stock Exchange's Securities Listing Regulations Article 434 and the Japan Securities Dealers Association’s Rules on Handling Third-Party Allotment Issuance, the company adhered strictly to the limits. The exercise ratio did not exceed the permissible limit of 0.00%.

PDFOriginal disclosureTDnet filing · Japanese · 15:30 JSTView original ↗
End of article